logo
Plus   Neg
Share
Email

Grifols To Begin Clinical Trial To Evaluate Plasma-derived COVID-19 Drug - Quick Facts

Grifols (GRFS), a global healthcare company, said it will begin a clinical trial in Spain to evaluate the safety and efficacy of a new COVID-19 drug based on immunoglobulin Gamunex-C and containing anti-SARS-CoV-2 polyclonal antibodies from plasma donors. The company expects the trial to begin in February 2021, with the possibility of results in the spring. About 800 patients, tested positive for the virus in a diagnostic test, will participate in the clinical study.

Grifols said the medicine, given subcutaneously, would provide immediate protection after exposure to the virus and could be used to protect the elderly and healthcare workers.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
South Korea's Hyundai Motor Co. announced its decision to suspend production at its Asan plant for two days starting on Monday due to a chip shortage amid the pandemic crisis, Reuters reported. The company is experiencing trouble in supply conditions for semiconductor parts for powertrain control units. The Asan factory manufactures 300,000 vehicles, including the Sonata and Grandeur sedans, each The U.S. Department of Health and Human Services is set to expand its Health Center COVID-19 Vaccine Program to include all HRSA-funded health centers. This will increase the total number of health centers that have been invited to join the program to 1,470 nationwide from the earlier 950. McDonald's Corp. is planning to hire 25,000 workers in its restaurants across Texas in April, reports said. In a three-day event from April 13 to 15, the fast-food chain is expected to hire for crew and management positions. During these hiring days, participating McDonald's restaurants in the state will be accepting applications and interviewing job seekers.
RELATED NEWS
Follow RTT